Comparison of Elecsys Anti-HCV II Assay With Other HCV Screening Assays
- 14 December 2015
- journal article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 30 (5) , 451-456
Abstract
Early detection of hepatitis C virus (HCV) is an important step in preventing progression to cirrhosis and hepatocellular carcinoma. Serologic assays for anti-HCV antibody are valuable first-line tests in the screening and diagnosis of HCV infection. This study's aim was to evaluate the sensitivity and specificity of Elecsys Anti-HCV II assay for HCV screening. A total of 1,044 routine sera, 20 known HCV-positive samples, plus 54 preselected weakly positive samples were tested for anti-HCV with Elecsys Anti-HCV II assay, Elecsys Anti-HCV assays, InTec HCV enzymoimmunoassay (EIA), and Livzon Anti-HCV EIA. Interference test was assessed with additional 423 specimens without clinical evidence of HCV infection: preselected HCV weak reactive samples; dialysis samples; anti-HBc (antibody to HBV core antigen) (+), anti-Treponema pallidum (+), and anti-HIV (+) sera; and samples form autoimmune/alcoholic hepatitis or systemic Lupus erythematosus (SLE). Discrepant results were evaluated with recombinant immunoblot assay. The seroconversion panels were evaluated to assess how early each assay could detect HCV infection. The specificity (99.81%) of the Elecsys Anti-HCV II assay was less than that with the two EIA comparison methods. However, false-negative results were easily seen in the EIA assays. When serial bleeds of HCV panels were compared with the above-mentioned methods, the assay detected acute HCV infection only 3.5 days after a positive HCV-RNA nucleic acid test and earlier than the comparator assays. Sensitivities and specificities of the anti-HCV assays were sufficiently high for use in this study. The Elecsys Anti-HCV II assay is suitable for screening and reliable early detection of HCV infection.Keywords
Funding Information
- Roche Diagnostics
This publication has 23 references indexed in Scilit:
- Performance evaluation of a new fourth-generation HIV combination antigen–antibody assayMedical Microbiology and Immunology, 2012
- High false‐negative rate of anti‐HCV among Egyptian patients on regular hemodialysisHemodialysis International, 2012
- Hepatitis C virus infection and biological falsepositive syphilis test: a single-center experienceHepatobiliary & Pancreatic Diseases International, 2011
- Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificityMedical Microbiology and Immunology, 2010
- Epidemiology of Hepatitis B and C Viruses: A Global OverviewClinics in Liver Disease, 2010
- HCV positivity rate in the seronegative blood donors in ChinaBiomedicine & Pharmacotherapy, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- The global burden of hepatitis CLiver International, 2009
- Dynamics of viremia in early hepatitis C virus infectionTransfusion, 2005
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004